Today's Top Stories


Hot Topics


Comment & Analysis »

Pharma Technology Focus – Issue 64

In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X’s work on antibacterial R&D, helping nanomedicines reach their...

Pharma Technology Focus – Issue 64
GlobalData Healthcare

With FDA approval secured, Flexion’s Zilretta poised to shake up knee osteoarthritis marketplace

With FDA approval secured, Flexion’s Zilretta poised to shake up knee osteoarthritis marketplace
GlobalData Healthcare

Big pharma fails to challenge UK price controls as court backs NICE

Big pharma fails to challenge UK price controls as court backs NICE
GlobalData Healthcare

FDA has given Mylan’s Copaxone generic the green light

FDA has given Mylan’s Copaxone generic the green light
Lopamudra Roy

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

Company Releases »

Manufacturer of Cleanroom Cleaning Supplies and Clothing

Cleanroom Connection
Manufacturer of Cleanroom Cleaning Supplies and Clothing

Eagle Cleanroom and Lab Brochure

Eagle MHC
Eagle Cleanroom and Lab Brochure

Pharmaceutical Hard Capsule Dissolution Equivalence

EMBO CAPS® by Suheung Pharmaceutical Hard Capsule Dissolution Equivalence

Veterinary Product Development and Registration

Triveritas
Veterinary Product Development and Registration

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Report: Indonesian pharmaceutical market to be worth $10.11bn by 2021

Report: Indonesian pharmaceutical market to be worth $10.11bn by 2021

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Belimumab: The frontrunner in Lupus clinical trials

Belimumab: The frontrunner in Lupus clinical trials